Get started
Author

Kate M. Warde

Observed names: Kate M Warde, Kate Warde, Warde, Kate
ORCID: 0000-0001-6147-294X
Observed ORCID: 0000-0001-6147-294X
OpenAlex ID: A5055505660
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner
2023 · Kate M. Warde, Lorenzo J. Smith, et al. · Nature Aging · 52
PDF
Age-related Changes in the Adrenal Cortex: Insights and Implications
2023 · Kate M Warde, Lorenzo J Smith, et al. · Journal of the Endocrine Society · 32
PDF
Liver X receptor inhibition potentiates mitotane-induced adrenotoxicity in ACC
2020 · Kate M Warde, Erik Schoenmakers, et al. · Endocrine Related Cancer · 18
PDF
Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma
2022 · Kate M Warde, Yi Jan Lim, et al. · Endocrinology · 12
PDF
Sublethal Hyperthermia Transiently Disrupts Cortisol Steroidogenesis in Adrenocortical Cells
2023 · Nathan Mullen, Padraig T Donlon, et al. · Endocrinology · 5
Investigating the Role of Cholesterol and Lipid Trafficking in Mitotane Resistance in Adrenocortical Carcinoma
2021 · Kate Warde, Yi-Jan Lim, et al. · Journal of the Endocrine Society · 2
PDF
Investigating the role of cholesterol and lipid trafficking in mitotane resistance in adrenocortical carcinoma
2021 · Kate Warde, Jan Lim Yi, et al. · Endocrine Abstracts · 1
Launching an independent research laboratory and scientific career: Tools for a rapidly changing landscape
2026 · Simon F. Roy, Amy C. Fan, et al. · The Journal of Experimental Medicine
PDF
MON-504 Investigating the Immunomodulatory Role of wnt5a in Adrenocortical Carcinoma
2025 · Yemi Imodoye, Kate Warde, et al. · Journal of the Endocrine Society
PDF
7427 Cellular Senescence As A Pro-Tumorigenic Process And Therapeutic Target In Adrenocortical Carcinoma
2024 · Lorenzo Smith, Kate Warde, et al. · Journal of the Endocrine Society
Hyperthermia-induced cell death in adrenocortical carcinoma: efficacy and mechanisms beyond caspase 3 apoptosis
2024 · Nathan Mullen, Padraig T. Donlon, et al. · Endocrine Abstracts
Unravelling mitotane resistance in adrenocortical carcinoma: exploring alterations in lipid metabolism
2024 · Mariam Hassany, Kate Warde, et al. · Endocrine Abstracts
OR16-04 Androgen Deprivation Restricts Anti-tumor Immunity In Adrenocortical Carcinoma
2023 · Kate M Warde, Lorenzo Smith, et al. · Journal of the Endocrine Society
PDF
PSUN16 Sublethal Hyperthermia Decreases Cellular Proliferation and Transiently Disrupts Steroidogenesis in Adrenal Cells
2022 · Nathan Mullen, Padraig T Donlon, et al. · Journal of the Endocrine Society
PDF
Sublethal hyperthermia decreases cellular proliferation and transiently disrupts steroidogenesis in adrenal cells
2022 · Nathan Mullen, Padraig Donlon, et al. · Endocrine Abstracts
Hyperthermia differentially affects cortisol and aldosterone secretion under stimulated conditions
2021 · Padraig Donlon, Nathan Mullen, et al. · Endocrine Abstracts
Hyperthermia as a Steroidogenic Inhibitor of Adrenodortical Cells, an Adrenal Sparing Treatment for Primary Aldosteronism?
2021 · Padraig T Donlon, Nathan Mullen, et al. · Journal of the Endocrine Society
PDF
The role of the liver X receptor in mitotane therapy in adrenocortical carcinoma
2020 · Warde, Kate · Arrow@dit (Dublin Institute of Technology)
SUN-216 Investigating the Role of the Liver X Receptor in Potentiating Mitotane Therapy in Adrenocortical Carcinoma
2020 · Kate Warde, Erik Shoenmakers, et al. · Journal of the Endocrine Society
PDF
Works count: 19
Citation count: 122
H-index: 5
I10-index: 4
Year
Topic
Type